Schering marketing team
This article was originally published in The Tan Sheet
Former J&J exec Deborah Jorn joins Schering-Plough as group VP-global allergy/respiratory marketing, primary care customer group, firm announces Sept. 21. Jorn will provide "marketing leadership on a global basis to drive the growth of the company's allergy and respiratory franchises," the firm says. Her responsibilities include "the incorporation of line extensions, combination therapies and other in-licensing opportunities." In addition to J&J, Jorn has held marketing positions at Pharmacia and Merck...
You may also be interested in...
A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.
Approval of Alaway Preservative Free (ketotifen fumarate, 0.035) comes 15 months after FDA submitted a complete response letter to Bausch and the active ingredient developer, Eton Pharmaceuticals.
Unfounded expectation some firms have for FDA to protect their investments in preparing successful NDI notifications is part of industry’s overall interest in increased regulation of the market, says Steven Tave, Office of Dietary Supplement Programs director.